Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Thu, 07/30/2020 - 18:21	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Thu, 07/30/2020 - 16:14	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Thu, 07/30/2020 - 14:11	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Thu, 07/30/2020 - 18:21	Opened		Gäst
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Thu, 07/30/2020 - 16:14	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Thu, 07/30/2020 - 14:11	Opened		Gäst
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Dr. Mattingly discute abordagens durante a pandemia	Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER